 |
|
|
| |
Incident Hypertension After Switching to Integrase Strand Transfer Inhibitors-Based ART, RESPOND Cohort
|
| |
| |
CROI 2026 Feb 22-25 Denver
Patrick Mallon1, Sean Fleming2, Girish Prajapati2, Hanaya Raad3, Vanessa Rascon Velasco3, Ramzi Argoubi3
1University College Dublin School of Medicine, Dublin, Ireland, 2Merck & Co., Inc., Rahway, New Jersey, United States, 3Oracle Life Sciences, Paris, France
from Jules: I do not see any consideration of weight or weight gain or BMI in risk for hypertension.
|
| |
|
|
|
|
|
